Hypoglycaemia, though uncommon with Ozempic alone, can cause irritability and should be monitored, especially with concurrent diabetes medications
Each approach has different evidence levels, timelines, and side effect profiles understanding the mechanisms helps in evaluating which compounds have the strongest research support for specific fat loss goals
Patients with T2DM tend to secrete less insulin following a glucose-heavy meal possibly due to decreased levels of glucagon-like peptide-1 (GLP-1) [96]
In a randomised controlled trial with over 1800 participants comparing tirzepatide to semaglutide, the tirzepatide group reported more serious adverse events (5-7% VS 3%) and higher discontinuation rates due to adverse events (6-8.5% VS 4%)
Reports of GLP-1 users developing scurvy have increased in recent months
Who is Eligible For Qsymia